This inventor holds 1 USPTO granted patent. Top assignee: University of Virginia Patent Foundation. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: W Michael Sheld: Innovator in Restenosis Treatment
Introduction
W Michael Sheld is a notable inventor based in Earlysville, Virginia. He has made significant contributions to the field of medical treatments, particularly in the area of restenosis. His innovative approach has led to the development of a unique method that addresses this critical health issue.
Latest Patents
W Michael Sheld holds a patent for a method for treating restenosis with A2A adenosine receptor agonists. This patent highlights the effectiveness of agonists of A adenosine receptors in combination with rolipram, its derivatives, or other Type IV phosphodiesterase (PDE) inhibitors for the treatment of restenosis. His work in this area has the potential to improve patient outcomes significantly.
Career Highlights
Sheld is affiliated with the University of Virginia, where he continues to engage in research and development. His career is marked by a commitment to advancing medical science and improving therapeutic options for patients suffering from restenosis.
Collaborations
Throughout his career, W Michael Sheld has collaborated with esteemed colleagues, including Joel M Linden and Gail W Sullivan. These partnerships have fostered a collaborative environment that enhances innovation and research in the medical field.
Conclusion
W Michael Sheld's contributions to the treatment of restenosis exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care.